3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2/3
1
Phase 2
1
Phase 1/2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Brain Neoplasms
2
Radiation Injuries
1
Prostatic Neoplasms
1
Popliteal Cyst
1
Pneumonia
1
Optic Neuritis
1
Myelitis, Transverse
1
Myelitis
1
Myasthenia Gravis
1
Glioma
1
Breast Neoplasms
1
Arthritis, Rheumatoid
1
Interventions
Radiosurgery
23
Radiotherapy
20
Temozolomide
17
Lomustine
9
Bevacizumab
8
Surgical Procedures, Operative
7
Procarbazine
6
Vincristine
5
Nivolumab
5
Memantine
5
Magnetic Resonance Spectroscopy
4
Filgrastim
4
Etoposide
4
Cisplatin
4
Carboplatin
4
Specimen Handling
3
Sodium Chloride
3
Radiation
3
Methylphenidate
3
Mental Status and Dementia Tests
3
Granulocyte Colony-Stimulating Factor
3
Gefitinib
3
Cyclophosphamide
3
Corticotropin-Releasing Hormone
3
Carmustine
3
icotinib
2
etoposide phosphate
2
efaproxiral
2
X-Rays
2
Tranexamic Acid
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Brain Neoplasms
×
Adrenal Cortex Hormones
×
Clear all
NCT06888817
2026-02-25
BRAINS
The Netherlands Cancer Institute
Phase 3
Recruiting
408 enrolled
NCT06471465
2025-08-17
BRADI
Institut Cancerologie de l'Ouest
Phase 3
Recruiting
84 enrolled